Overcoming Key Regulatory Issues in Cell and Gene Therapies with Reliable and Expansive Expertise

For this short interview, Emma Cheesman-Ungstrup, Director of Development Consulting and Scientific Affairs at Biopharma Excellence, describes a few of her key takeaways from a panel discussion hosted at Advanced Therapies Week 2022.

Start a conversation today